Earlier today, we reported how Mackenzie Health continues to advance its Innovation Strategy with the launch of Phase Two of the Innovation Unit.
In a report published Wednesday, Credit Suisse analyst Kulbinder Garcha maintained an Underperform rating on BlackBerry with a price target of $6, after the company reported disappointing results.
Mackenzie Health continues to advance its Innovation Strategy with the launch of Phase Two of the Innovation Unit.
BlackBerry announced on Tuesday that quarterly revenue came in at $658m, down from $966m in the year-ago quarter, and a slight decrease from $660m in Q4.
BlackBerry today announced that they have entered into a long-term patent cross-licensing agreement covering their respective products and technologies.
BlackBerry today announced that it has appointed Laurie Smaldone Alsup, M.D., President and Chief Scientific Officer of PharmApprove, to the Company's Board of Directors
BlackBerry today reported financial results for the three months ended May 30, 2015 (all figures in U.S. dollars and U.S. GAAP, except where otherwise indicated).
SACO LLC has entered a global master distribution agreement with BlackBerry to serve customers in the Americas.
Emberify has announced that they have released Instant v3.0 for BlackBerry 10. Instant is a lifestyle app that will automatically track the time spent on the BlackBerry device each day and how many times you check it.
BlackBerry’s cloud-based enterprise mobility management (EMM) solution, BES12 Cloud, has been certified through the HP Helion Ready Program.
BlackBerry has officially started the rollout of OS 10.3.2 to users in the U.S., beginning with BlackBerry Classic users on Verizon and T-Mobile networks today.
BlackBerry will be reporting results for the first quarter of fiscal 2016 on Tuesday, June 23rd, 2015. Just after it, the company will hold its Annual and Special Meeting of Shareholders at 10am ET in Waterloo, Ontario.
